RAP 0.00% 20.5¢ resapp health limited

Revenue, page-3

  1. Dhm
    2,378 Posts.
    lightbulb Created with Sketch. 3488
    Really?

    It's all about the disruptive nature of the products and the fact that there are no realistic competitors in either the respiratory and sleep apnea marketplaces. Ping An do over 600,000 consultations a day, with respiratory ailments accounting for roughly 30-40%.

    But I suspect you know all about this already, otherwise you wouldn't ask such a naive question.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.